Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, Tyler J., Wei, Shuang, Dong, Haidong, Alvarez, Xavier, Cheng, Pui, Mottram, Peter, Krzysiek, Roman, Knutson, Keith L. +14 more·2003·Nature Medicine

DOI 10.1038/nm863

Cited by (1,000)

Items 201–300 of 1,000

Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
Robert Houston Thompson, Haidong Dong, Eugene D. Kwon · 2007 · Clinical Cancer Research
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego Omar Croci, Mariano F. Zacarías Fluck, María José Rico, Pablo Matar, Gabriel A. Rabinovich, Olga Graciela Scharovsky · 2007 · Cancer Immunology Immunotherapy
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Robert D. Leone, Ying-Chun Lo, Jonathan D. Powell · 2015 · Computational and Structural Biotechnology Journal
Deciphering the role of Th17 cells in human disease
Cailin Moira Wilke, Keith Bishop, David A. Fox, Weiping Zou · 2011 · Trends in Immunology
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Alexandra Schnell, Lloyd Bod, Asaf Madi, Vijay Kumar Kuchroo · 2020 · Cell Research
Overcoming Immune Evasion in Melanoma
Kevinn Eddy, Suzie Chen · 2020 · International Journal of Molecular Sciences
Tumor–Host Immune Interactions and Dendritic Cell Dysfunction
Li Yang, David Paul Carbone · 2004 · Advances in cancer research
Current Status and Future Directions
Fumito Ito, Alfred E. Chang · 2013
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
Yuka Igarashi, Tetsuro Sasada · 2020 · Journal of Immunology Research
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox, Andrew L. Feldman, David A. Wada, Zhi‐Zhang Yang, Nneka I. Comfere, Haidong Dong, Eugene D. Kwon, Anne Josephine Novak, Svetomir N. Markovic, Mark R. Pittelkow et al. · 2009 · Blood
Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection
Sang‐Jun Ha, Scott N. Mueller, E. John Wherry, Daniel L. Barber, Rachael D. Aubert, Arlene H. Sharpe, Gordon James Freeman, Rafi Ahmed · 2008 · The Journal of Experimental Medicine
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity
Juan R. Cubillos‐Ruiz, Xavier A. Engle, Uciane K. Scarlett, Diana G. Martinez, Amorette E. Barber, Raúl Elgueta, Li Wang, Yolanda C. Nesbeth, Yvon G. Durant, Andrew T. Gewirtz et al. · 2009 · Journal of Clinical Investigation
Combinations of Bevacizumab With Cancer Immunotherapy
Daniel S. Chen, Herbert I. Hurwitz · 2018 · The Cancer Journal
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Olga K. Afanasiev, Lola Yelistratova, Natalie J. Miller, Kotaro Nagase, Kelly Garneski Paulson, Jayasri G. Iyer, Dafina Ibrani, David M. Koelle, Paul Nghiem · 2013 · Clinical Cancer Research
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
Fabian Finkelmeier, Özge Canli, Andrea Oliver Tal, Thomas Pleli, Jörg Trojan, Michael Schmidt, Bernd Kronenberger, Stefan Zeuzem, Albrecht Piiper, Florian R. Greten et al. · 2016 · European Journal of Cancer
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
Tsvetelina Pentcheva‐Hoang, Emily Corse, James Patrick Allison · 2009 · Immunological Reviews
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
Yongkui Li, Min Fang, Jian Zhang, Jian Wang, Yu Song, Jie Shi, Wei Li, Gang Wu, Jinghua Ren, Zheng Wang et al. · 2015 · OncoImmunology
Neutrophils as active regulators of the immune system in the tumor microenvironment
Merav E. Shaul, Zvi Gregorio Fridlender · 2017 · Journal of Leukocyte Biology
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika, William A. Hammond, Richard Wayne Joseph · 2015 · Molecular Immunology
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Ivraym B. Barsoum, Madhuri Koti, David Robert Siemens, Charles H. Graham · 2014 · Cancer Research
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen, Wenjun Ouyang, Lawren C. Wu · 2020 · Immunity
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment
Wen Li, Feifei Li, Xia Zhang, Hui‐Kuan Lin, Chuan Shan Xu · 2021 · Signal Transduction and Targeted Therapy
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
Xi Chen, Xiaohui Pan, Wenxin Zhang, Hongjie Guo, Shuyuan Cheng, Qiaojun He, Bo Yang, Ling Ding · 2019 · Acta Pharmaceutica Sinica B
Immune Resistance in Lung Adenocarcinoma
Μάγδα Σπέλλα, Georgios T. Stathopoulos · 2021 · Cancers
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Min‐Seok Rha, Eui‐Cheol Shin · 2021 · Cellular and Molecular Immunology
EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1
Wang, Jie, Ge, Junshang, Wang, Yian, Xiong, Fang, Guo, Jiayue, Jiang, Xianjie, Zhang, Lishen, Deng, Xiangying, Gong, Zhaojian, Zhang, Shanshan et al. · 2022 · Nature Communications
A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
Samit Chatterjee, Wojciech G. Lesniak, Matthew Gabrielson, Ala Lisok, Bryan L. Wharram, Polina Sysa‐Shah, Babak Behnam Azad, Martin G. Pomper, Sridhar Nimmagadda · 2016 · Oncotarget
Soluble CD276 (B7‐H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
Guangbo Zhang, Jianquan Hou, Jinfang Shi, Gehua Yu, Binfeng Lu, Xueguang Zhang · 2008 · Immunology
Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
Tae Kon Kim, Roy S. Herbst, Lieping Chen · 2018 · Trends in Immunology
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
Jing Li, Weichao Wang, Yajia Zhang, Marcin P. Cieslik, Jipeng Guo, Mengyao Tan, Michael D. Green, Weimin Wang, Heng Lin, Wei Li et al. · 2020 · Journal of Clinical Investigation
Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell–Mediated Inflammation and Immunosuppression
Wenwen Xu, Juan Dong, Yongwei Zheng, Juan Zhou, Ying Yuan, Hieu Minh Ta, Halli E. Miller, Michael Olson, Kamalakannan Rajasekaran, Marc S. Ernstoff et al. · 2019 · Cancer Immunology Research
Personalized Dendritic Cell Vaccines‐Recent Breakthroughs and Encouraging Clinical Results
Mastelic-Gavillet, Beatris, Balint, Klara, Boudousquie, Caroline, Gannon, Philippe O., Kandalaft, Lana E. · 2019 · Frontiers in Immunology
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss, Andrew S. Flies, Lijie Zhen, Rubin M. Tuder, Joseph F. Grosso, Timothy Harris, Derese Getnet, Katharine A. Whartenby et al. · 2007 · Blood
PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
Fabienne McClanahan, Bola S. Hanna, Shaun Miller, Andrew James Clear, Peter Lichter, John G. Gribben, Martina Seiffert · 2015 · Blood
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang, Yongkui Li, Kai Huang, Shanshan Qi, Jian Zhang, Witold Zgodziński, Marek Majewski, Grzegorz T. Wallner, Stanisław S. Góźdź, Paweł Macek et al. · 2017 · Cancer Research
Cutting Edge: Opposite Effects of IL-1 and IL-2 on the Regulation of IL-17+ T Cell Pool IL-1 Subverts IL-2-Mediated Suppression
Ilona Kryczek, Shuang Wei, Linhua Vatan, June F Escara-Wilke, Wojciech Szeliga, Evan T. Keller, Weiping Zou · 2007 · The Journal of Immunology
Schistosoma mansoni Worms Induce Anergy of T Cells via Selective Up-Regulation of Programmed Death Ligand 1 on Macrophages
Philip Smith, Caitríona M. Walsh, Niamh E. Mangan, Rosie E. Fallon, Jon R. Sayers, Andrew N. J. McKenzie, Padraic G. Fallon · 2004 · The Journal of Immunology
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain · 2024 · International Immunopharmacology
Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
Salem Chouaı̈b, Yosra Messai, Sophie Couvé, Bernard J. Escudier, Meriem Hasmim, Muhammad Zaeem Noman · 2012 · Frontiers in Immunology
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis
Aurore Saudemont, Bruno Quesnel · 2004 · Blood
CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy
Anke Kretz-Rommel, Fenghua Qin, Naveen K. Dakappagari, Edward P. Ravey, John R. McWhirter, Daniela I. Oltean, Shana Frederickson, Toshiaki Maruyama, Martha A. Wild, Mary Jean Nolan et al. · 2007 · The Journal of Immunology
FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Ilona Kryczek, Rebecca Liu, Guobin Wang, Ke Wu, Xiaogong Shu, Wojciech Szeliga, Linhua Vatan, Emily V. A. Finlayson, Emina H. Huang, Diane M. Simeone et al. · 2009 · Cancer Research
Inducible Expression of B7-H1 (PD-L1) and Its Selective Role in Tumor Site Immune Modulation
Miguel F. Sanmamed, Lieping Chen · 2014 · The Cancer Journal
PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Alexander W. Macfarlane, Mowafaq Jillab, Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Samuel Litwin, Essel Dulaimi, Tahseen Al‐Saleem, Kerry S. Campbell · 2013 · Cancer Immunology Research
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
Zili Gu, Candido G. Da Silva, Koen van der Maaden, FERRY A. OSSENDORP, Luis Javier Cruz · 2020 · Pharmaceutics
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
Carmen M. Anadon, Xiaoqing Yu, Kay Hänggi, Subir Biswas, Ricardo A. Chaurio, Alexandra Martin, Kyle K. Payne, Gunjan Mandal, Patrick Innamarato, Carly M. Harro et al. · 2022 · Cancer Cell
Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
Takashi Tanikawa, Cailin Moira Wilke, Ilona Kryczek, Grace Chen, John Y. Kao, Gabriel Núñez, Weiping Zou · 2011 · Cancer Research
Ovarian Cancer Immunotherapy Using PD‐L1 siRNA Targeted Delivery from Folic Acid‐Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
Pei Y. Teo, Chuan He Yang, Lynsey May Whilding, Ana C. Parente‐Pereira, John F. Maher, Andrew J.T. George, James L. Hedrick, Yi Yan Yang, Sadaf Ghaem‐Maghami · 2015 · Advanced Healthcare Materials
Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma
Robert Houston Thompson, Michael D. Gillett, John C. Cheville, Christine Marie Lohse, Haidong Dong, W. Scott Webster, Lieping Chen, Horst Zincke, Michael L. Blute, Bradley C. Leibovich et al. · 2005 · Cancer
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway
Piao Li, Tingting Huang, Qi Zou, Dian Liu, Yihua Wang, Ximin Tan, Wei Yao, Hong Qiu · 2019 · The Journal of Immunology
The Role of Tumor Microenvironment in Cancer Immunotherapy
Frankel, Timothy, Lanfranca, Mirna Perusina, Zou, Weiping · 2017 · Advances in Experimental Medicine and Biology
The impact of T‐cell immunity on ovarian cancer outcomes
Brad H. Nelson · 2008 · Immunological Reviews
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Walter Krempski, Deborah A. Bahr, Joshua I. Daum, Kimberly R. Kalli, Ellen L. Goode, Matthew Stephen Block, Martin J. Cannon et al. · 2017 · Cancer Research
GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response
Cohen, Nicolas, Mouly, Enguerran, Hamdi, Haifa, Maillot, Marie-Christine, Pallardy, Marc, Godot, Véronique, Capel, Francis, Balian, Axel, Naveau, Sylvie, Galanaud, Pierre et al. · 2006 · Blood
Clinical importance of B7-H3 expression in human pancreatic cancer
I Yamato, Masayuki Sho, Takeo Nomi, T Akahori, Keiji Shimada, Kiyohiko Hotta, H Kanehiro, N Konishi, Hideo Yagita∥, Y. Nakajima · 2009 · British Journal of Cancer
Renal cell carcinoma programmed death-ligand 1, a new direct target of hypoxia-inducible factor-2 alpha, is regulated by von Hippel–Lindau gene mutation status
Messai, Yosra, Gad, Sophie, Noman, Muhammad Zaeem, Le Teuff, Gwenael, Couve, Sophie, Janji, Bassam, Kammerer, Solenne Florence, Rioux-Leclerc, Nathalie, Hasmim, Meriem, Ferlicot, Sophie et al. · 2016 · European Urology
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
Céline Berthon, Virginie Driss, Jizhong Liu, Klaudia Kuranda, Xavier P Leleu, Nathalie Jouy, Dominique Hétuin, Bruno Quesnel · 2010 · Cancer Immunology Immunotherapy
Dendritic Cells and Tumor Microenvironment: A Dangerous Liaison
Ingo Fricke, Dmitry I. Gabrilovich · 2006 · Immunological Investigations
Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell–Mediated Killing
Hua Laura Liang, Liufu Deng, Steven J. Chmura, Byron Burnette, Nicole Liadis, Thomas E. Darga, Michael A Beckett, Mark William Lingen, Mary Ellyn Witt, Ralph R. Weichselbaum et al. · 2013 · The Journal of Immunology
Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh, Soghra Bornehdeli, Haniye Mohahammadrezakhani, Mahsa Abolghasemi, Elham Poursaei, Milad Asadi, Venus Zafari, Leili Aghebati Maleki, Dariush Shanehbandi · 2020 · Life Sciences
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma, Giusy Gentilcore, Kia Heimersson, Fariba Mozaffari, Barbro Näsman‐Glaser, Emma Young, Richard Rosenquist, Lotta Hansson, Anders Österborg, Håkan Mellstedt · 2016 · Haematologica
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?
Michael R. Shurin, Galina V. Shurin, Anna E Lokshin, Zoya R. Yurkovetsky, Dmitry W. Gutkin, Gurkamal S. Chatta, Hua Zhong, Baohui Han, Robert Louis Ferris · 2006 · Cancer and Metastasis Reviews
Survival in cancer of unknown primary site: population-based analysis by site and histology
Kari Hemminki, Melanie Bevier, Akseli Hemminki, Jan Sundquist · 2011 · Annals of Oncology
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Jessica M. Moskovitz, Jennifer D. Moy, Robert Louis Ferris · 2018 · Current Oncology Reports
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
Sumit Kumar Subudhi, Ping Zhou, Lisa M. Yerian, Robert Chin, James C. Lo, Robert A. Anders, Yonglian Sun, Lieping Chen, Yang Wang, Maria‐Luisa Alegre et al. · 2004 · Journal of Clinical Investigation
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway
Junghwa Lee, Eunseon Ahn, Haydn Thomas Kissick, Rafi Ahmed · 2015 · Forum on Immunopathological Diseases and Therapeutics
Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
Ellen C. Moore, Paúl E. Clavijo, Ruth J. Davis, Harrison A. Cash, Carter Van Waes, Young Kim, Clint Tanner Allen · 2016 · Cancer Immunology Research
The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
Linda Quatrini, Francesca Romana Mariotti, Enrico Munari, Nicola Tumino, Paola Vacca, Lorenzo Moretta · 2020 · Cancers
Heparanase and the hallmarks of cancer
Krishnath M. Jayatilleke, Mark D. Hulett · 2020 · Journal of Translational Medicine
PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, Anton I. Skaro, Ephraim Shin-Tian Tang, Xiufen Zheng · 2023 · Cancer Immunology Immunotherapy
Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens
Masashi Iwasaki, Yoshimasa Tanaka, Hirohito Kobayashi, Kaoru Murata‐Hirai, Hideto Miyabe, Tomoharu Sugie, Masakazu Toi, Nagahiro Minato · 2010 · European Journal of Immunology
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours
Helen Conroy, Neil A. Marshall, Kingston H. G. Mills · 2008 · Oncogene
B7-H1 Blockade Increases Survival of Dysfunctional CD8+ T Cells and Confers Protection against Leishmania donovani Infections
Trupti Joshi, Susana Rodriguez, Vladimir Perović, Ian Andrew Cockburn, Simona Stäger · 2009 · PLoS Pathogens
Immunotherapeutic Approaches for Glioma
Hideho Okada, Gary Kohanbash, Xinmei Zhu, Edward R. Kastenhuber, Aki Hoji, Ryo Ueda, Mitsugu Fujita · 2009 · Critical Reviews in Immunology
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
Gaopeng Li, Jae Eun Choi, Ilona Kryczek, Yilun Sun, Peng Liao, Shasha Li, Shuang Wei, Sara Grove, Linda Vatan, Reagan Nelson et al. · 2023 · Cancer Cell
Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression
Murugabaskar Balan, Eduardo Mier y Teran, Ana Maria Waaga-Gasser, Martin Gasser, Toni K. Choueiri, Gordon James Freeman, Soumitro Pal · 2015 · Journal of Biological Chemistry
Immune checkpoint inhibition in ovarian cancer
Junzo Hamanishi, Masaki Mandai, Ikuo Konishi · 2016 · International Immunology
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Jing Liu, Zhihao Zhao, Nasha Qiu, Quan Zhou, Guowei Wang, Haiping Jiang, Ying Piao, Zhuxian Zhou, Jianbin Tang, Youqing Shen · 2021 · Nature Communications
Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
Robin Maximilian Awad, Yannick De Vlaeminck, Johannes Maebe, Cleo Goyvaerts, Karine Breckpot · 2018 · Frontiers in Immunology
Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
Hallett, William H.D., Jing, Weiqing, Drobyski, William R., Johnson, Bryon D. · 2011 · Biology of Blood and Marrow Transplantation
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
Martin Loos, Nathalia A. Giese, Jorg H. Kleeff, Thomas Giese, Matthias M. Gaida, Frank Bergmann, Melanie Laschinger, Markus Wolfgang Büchler, Helmut Frieß · 2008 · Cancer Letters
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
Paul C. McDonald, Shawn C. Chafe, Shoukat Dedhar · 2016 · Frontiers in Cell and Developmental Biology
Sex and Gender Disparities in Melanoma
Maria Bellenghi, Rossella Puglisi, Giada Pontecorvi, Alessandra De Feo, Alessandra Carè, Gianfranco Mattia · 2020 · Cancers
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Trina J. Stewart, Mark John Smyth · 2011 · Cancer and Metastasis Reviews
Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity
Houjun Xia, Wei Wang, Joel Crespo, Ilona Kryczek, Wei Li, Shuang Wei, Zhaoqun Bian, Tomasz Maj, Ming‐Xiao He, J Rebecca Liu et al. · 2017 · Science Immunology
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Ende Zhao, Lin Wang, Jinlu Dai, Ilona Kryczek, Shuang Wei, Linda Vatan, Saleh Altuwaijri, Tim D. Sparwasser, Guobin Wang, Evan T. Keller et al. · 2012 · OncoImmunology
Immune checkpoint inhibitors in cancer therapy
S. Eika, Liu Peng, Renato B. Baleeiro, R. Nicholas, Yuan Ming, Wang Yaohe · 2017 · Journal of Biomedical Research
Hypoxia: a Double-Edged Sword in Cancer Therapy
Manoochehri Khoshinani, Hamed, Afshar, Saeid, Najafi, Rezvan · 2016 · Cancer Investigation
Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma
Shari Pilon‐Thomas, Amy Mackay, Nasreen A. Vohra, James J. Mulé · 2010 · The Journal of Immunology
Immunotherapy for Ovarian Cancer: What's Next?
Lana Elias Kandalaft, Daniel J. Powell, Nathan Singh, George Coukos · 2010 · Journal of Clinical Oncology
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy
Wan Du, Timothy L. Frankel, Michael Green, Weiping Zou · 2021 · Cellular and Molecular Immunology
PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
Nataša Obermajer, Jeffrey L. Wong, Robert P. Edwards, Kunle O. Odunsi, Kirsten B. Moysich, Paweł Kaliński · 2012 · Immunological Investigations
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
Karl S. Peggs, Sergio A. Quezada, James Patrick Allison · 2009 · Clinical & Experimental Immunology
Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines
Afifaa Butt, Kingston H. G. Mills · 2013 · Oncogene
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Mohammad Davoodzadeh Gholami, Gholam Ali Kardar, Yousef Saeedi, Sahel Heidari, Johan Garssen, Reza Falak · 2017 · Cellular Immunology
Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma
Iñigo Tirapu, Eduardo Huarte, Cristiana Guiducci, Ainhoa Arina, Mikel Zaratiegui, Oihana Murillo, Álvaro González, Carmen Berasain, Pedro Berraondo, Puri Fortes et al. · 2006 · Cancer Research
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, Cailin Moira, Wei, Shuang, Wang, Lin, Kryczek, Ilona, Kao, John, Zou, Weiping · 2011 · Cancer Immunology Immunotherapy
Consensus nomenclature for CD8+T cell phenotypes in cancer
Lionel Apétoh, Mark John Smyth, Charles G. Drake, Jean‐Pierre Abastado, Ron N. Apte, Maha Ayyoub, Jean‐Yves Blay, Marc Bonneville, Lisa Helene Butterfield, Anne Caignard et al. · 2015 · OncoImmunology
B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
Pei-Yi Lin, Lishi Sun, Suzanne R. Thibodeaux, Sara M. Ludwig, Ratna K. Vadlamudi, Vincent J. Hurez, Rumana Bahar, Mark J. Kious, Carolina Becker Livi, Shawna R. Wall et al. · 2010 · The Journal of Immunology
Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma
Elie Rassy, Ronan Flippot, Laurence K. Albiges · 2020 · Therapeutic Advances in Medical Oncology